As previously communicated,
The collaboration began in
About V.A Cure
V.A Cure is a Horizon 2020 funded project that aims to uncover core mechanisms of vascular anomalies and leverage this information to establish new therapeutics for vascular disease. The project consists of 14 individual research projects across seven academic labs and two industry partners.
Vascular anomalies are defects of the vascular system that can be either with blood or lymph vessels. Many vascular anomalies are congenial and inherited, but they can also be brought on by events such as trauma and pregnancy. In addition, vascular anomalies can be malformations or tumors, ranging from harmless to life-threatening.
For more information about V.A Cure, follow the link to https://vacure.eu/.
For more information, please contact:
Email: patrik.sundh@clinescientific.com
Phone: +46 0703585088
Argongatan 2 C Email: info@clinescientific.com
431 53 MÖLNDAL Website: www.clinescientific.com
About Cline Scientific
Cline Scientific develops advanced cancer diagnostics and regenerative medicine treatments. The company is working heavily with R&D through joint collaborations with pharmaceutical companies and academic researchers around the world. The focus is on projects in the cancer diagnostic and stem cell therapy fields since Clines nanotechnology here provides unmet solutions to critical challenges and functions. The unique patented surface nanotechnology is used in cell-based products and processes to drive projects within Life Science into and through the clinical phase.
https://news.cision.com/cline/r/cline-scientific-extends-collaboration-agreement-with-astrazeneca,c3487065
https://mb.cision.com/Main/12114/3487065/1521113.pdf
(c) 2022 Cision. All rights reserved., source